주식/증권
➡️ 중립
관련 뉴스
Neurocrine expects double-digit 2027 INGREZZA volume growth despite mid- to high single-digit net pricing headwinds
11/03/2026
Ichor signals full year 2026 revenue growth of roughly 30% while targeting 16.5% Q4 gross margin
11/03/2026
Fabrinet anticipates Q2 revenue of $1.6B-$1.65B while starting Building 11 with ~$3B capacity
11/03/2026
Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M
11/03/2026